foxo4-dri human trial Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI (Proxofim) (10mg)
FOXO4 DRI (Proxofim) (10mg) FOXO4 DRI Peptide 10 mg FOXO4 Dri 10mg FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOX04 DRI Apollo Peptide Sciences
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




